Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ascani

Showing results (351-360 of 361) with videos related to

Pageof 37
Sort By:
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor MicroenvironmentAndrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findingsFiliberto Belli, Alessandro Testori, Licia Rivoltini, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Cancer Medicine|September 27, 2016
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markersMarco Lucioni, Emilio Berti, Luca Arcaini, et al.
Cells|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation VariablesAndrea Palicelli, Martina Bonacini, Stefania Croci, et al.
Blood|August 3, 2021
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AMLMaria Paola Martelli, Roberta Rossi, Alessandra Venanzi, et al.
Cells|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic CorrelationsAndrea Palicelli, Martina Bonacini, Stefania Croci, et al.
Haematologica|July 18, 2024
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypesGrazia Gargano, Maria Carmela Vegliante, Flavia Esposito, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2014
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter studyRossano Lattanzio, Rossana La Sorda, Francesco Facciolo, et al.
Oral and Maxillofacial Surgery|December 13, 2023
Changes in hospital admissions for facial fractures during and after COVID 19 pandemic: national multicentric epidemiological analysis on 2938 patientsMarzia Petrocelli, Federica Ruggiero, Davide Allegri, et al.
Pageof 37

Showing results (351-360 of 361) with videos related to

Sort By:
Pageof 37
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 3: PD-L1, Intracellular Signaling Pathways and Tumor MicroenvironmentAndrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 16, 2002
Vaccination of metastatic melanoma patients with autologous tumor-derived heat shock protein gp96-peptide complexes: clinical and immunologic findingsFiliberto Belli, Alessandro Testori, Licia Rivoltini, et al.
International Journal of Molecular Sciences|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 5: Epigenetic Regulation of PD-L1Andrea Palicelli, Stefania Croci, Alessandra Bisagni, et al.
Cancer Medicine|September 27, 2016
Primary cutaneous B-cell lymphoma other than marginal zone: clinicopathologic analysis of 161 cases: Comparison with current classification and definition of prognostic markersMarco Lucioni, Emilio Berti, Luca Arcaini, et al.
Cells|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 1: Focus on Immunohistochemical Results with Discussion of Pre-Analytical and Interpretation VariablesAndrea Palicelli, Martina Bonacini, Stefania Croci, et al.
Blood|August 3, 2021
Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AMLMaria Paola Martelli, Roberta Rossi, Alessandra Venanzi, et al.
Cells|November 27, 2021
What Do We Have to Know about PD-L1 Expression in Prostate Cancer? A Systematic Literature Review. Part 2: Clinic-Pathologic CorrelationsAndrea Palicelli, Martina Bonacini, Stefania Croci, et al.
Haematologica|July 18, 2024
A targeted gene signature stratifying mediastinal gray zone lymphoma into classical Hodgkin lymphoma-like or primary mediastinal B-cell lymphoma-like subtypesGrazia Gargano, Maria Carmela Vegliante, Flavia Esposito, et al.
Lung Cancer (Amsterdam, Netherlands)|June 9, 2014
Thymic epithelial tumors express vascular endothelial growth factors and their receptors as potential targets of antiangiogenic therapy: a tissue micro array-based multicenter studyRossano Lattanzio, Rossana La Sorda, Francesco Facciolo, et al.
Oral and Maxillofacial Surgery|December 13, 2023
Changes in hospital admissions for facial fractures during and after COVID 19 pandemic: national multicentric epidemiological analysis on 2938 patientsMarzia Petrocelli, Federica Ruggiero, Davide Allegri, et al.
Pageof 37